当前位置:首页 - 行情中心 - 颖泰生物(920819) - 财务分析 - 现金流量表

颖泰生物

(920819)

  

流通市值:51.20亿  总市值:51.97亿
流通股本:12.08亿   总股本:12.26亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,995,892,498.932,020,307,381.89975,522,032.243,747,079,671.08
  收到的税费返还208,138,076.85130,219,005.9280,466,713.55275,818,093.54
  收到其他与经营活动有关的现金57,009,660.7531,701,815.6514,851,619.97101,681,191.37
  经营活动现金流入小计3,261,040,236.532,182,228,203.461,070,840,365.764,124,578,955.99
  购买商品、接受劳务支付的现金2,272,915,209.441,399,070,218.78750,417,827.922,793,576,424.61
  支付给职工以及为职工支付的现金503,742,692.79352,952,905200,446,346.59675,550,479.15
  支付的各项税费110,447,062.3183,625,731.8757,538,441.78126,339,882.31
  支付其他与经营活动有关的现金180,288,315.05123,890,887.7758,379,557.92279,222,019.55
  经营活动现金流出小计3,067,393,279.591,959,539,743.421,066,782,174.213,874,688,805.62
  经营活动产生的现金流量净额193,646,956.94222,688,460.044,058,191.55249,890,150.37
二、投资活动产生的现金流量:
  收回投资收到的现金70,000,00070,000,00030,000,000188,000,000
  取得投资收益收到的现金21,137,967.215,573,668.5-17,947,368.36
  处置固定资产、无形资产和其他长期资产收回的现金净额23,332,803.8417,036,197.11,550,00022,666,405.89
  收到的其他与投资活动有关的现金---2,210,642.31
  投资活动现金流入小计114,470,771.04102,609,865.631,550,000230,824,416.56
  购建固定资产、无形资产和其他长期资产支付的现金141,659,531.9693,458,652.3674,486,078.56460,725,865.41
  投资支付的现金---152,000,000
  支付其他与投资活动有关的现金242,000242,000242,0003,268,500
  投资活动现金流出小计141,901,531.9693,700,652.3674,728,078.56615,994,365.41
  投资活动产生的现金流量净额-27,430,760.928,909,213.24-43,178,078.56-385,169,948.85
三、筹资活动产生的现金流量:
  取得借款收到的现金3,880,081,175.011,960,726,124.571,071,983,414.764,857,390,702.44
  收到其他与筹资活动有关的现金70,185,620.8910,843,281.464,655,142.8516,624,935.81
  筹资活动现金流入小计3,950,266,795.91,971,569,406.031,076,638,557.614,874,015,638.25
  偿还债务支付的现金3,836,691,523.822,011,627,711.67831,027,301.714,604,201,291.46
  分配股利、利润或偿付利息支付的现金127,014,207.6181,744,306.0839,317,475.48305,368,962.3
  其中:子公司支付给少数股东的股利、利润3,780,0003,780,000-3,222,000
  支付其他与筹资活动有关的现金198,623,385.19147,028,382.95122,732,367.2434,084,307.76
  筹资活动现金流出小计4,162,329,116.622,240,400,400.7993,077,144.434,943,654,561.52
  筹资活动产生的现金流量净额-212,062,320.72-268,830,994.6783,561,413.18-69,638,923.27
四、汇率变动对现金及现金等价物的影响8,140,819.217,303,518.758,478,381.3825,740,043.6
五、现金及现金等价物净增加额-37,705,305.49-29,929,802.6452,919,907.55-179,178,678.15
  加:期初现金及现金等价物余额528,856,916.01528,856,916.01527,833,342.69708,035,594.16
  期末现金及现金等价物余额491,151,610.52498,927,113.37580,753,250.24528,856,916.01
补充资料:
  净利润-12,962,119.77--595,980,085.88
  资产减值准备---276,155,710.13
  固定资产和投资性房地产折旧-224,374,236.01-368,126,213.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-224,374,236.01-368,126,213.84
  无形资产摊销---41,008,230.34
  长期待摊费用摊销-4,676,919.32-5,029,638.05
  处置固定资产、无形资产和其他长期资产的损失--11,784,053.1--3,207,056.93
  固定资产报废损失-2,477,114.29-7,580,376.98
  公允价值变动损失--1,178,100.54--
  财务费用-68,462,687.92-140,398,757.8
  投资损失--20,751,086.12-226,970,520.98
  递延所得税--12,872,437.54--65,818,926.91
  其中:递延所得税资产减少--10,811,088.84--64,556,201.79
    递延所得税负债增加--2,061,348.7--1,262,725.12
  存货的减少-82,257,883.44-320,948,359.63
  经营性应收项目的减少-1,132,942.63--605,449,757.8
  经营性应付项目的增加--156,668,821.1-115,811,678.14
  其他---4,502,792.48
  现金的期末余额-498,927,113.37-528,856,916.01
  减:现金的期初余额-884,664,117.62-708,035,594.16
  现金及现金等价物的净增加额--385,737,004.25--179,178,678.15
公告日期2025-10-242025-08-152025-04-182025-04-18
审计意见(境内)标准无保留意见
TOP↑